Letter: combination of biologics in inflammatory bowel diseases. Authors' reply
- PMID: 32656846
- DOI: 10.1111/apt.15919
Letter: combination of biologics in inflammatory bowel diseases. Authors' reply
Comment on
-
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease.Aliment Pharmacol Ther. 2020 Jun;51(11):1031-1038. doi: 10.1111/apt.15719. Epub 2020 Apr 24. Aliment Pharmacol Ther. 2020. PMID: 32329532 Free PMC article.
-
Letter: combination of biologics in inflammatory bowel diseases.Aliment Pharmacol Ther. 2020 Aug;52(3):566-567. doi: 10.1111/apt.15891. Aliment Pharmacol Ther. 2020. PMID: 32656825 No abstract available.
References
REFERENCES
-
- Fumery M, Yzet C, Brazier F. Editorial: combination of biologics in inflammatory bowel diseases. Aliment Pharmacol Ther. 2020; 52:566-567.
-
- Yang E, Panaccione N, Whitmire N, et al. Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease. Aliment Pharmacol Ther. 2020;51:1031-1038.
-
- Feagan BG, Sandborn WJ, Colombel JF, et al. Incidence of arthritis/arthralgia in inflammatory bowel disease with long-term vedolizumab treatment: post hoc analyses of the GEMINI trials. J Crohn's Colitis. 2019;13:50-57.
-
- Hirten RP, Iacucci M, Shah S, Ghosh S, Colombel J-F. Combining biologics in inflammatory bowel disease and other immune mediated inflammatory disorders. Clin Gastroenterol Hepatol. 2018;16:1374-1384.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical